争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 8 条
2019
Stryker宣布对部分LIFEPAK 15设备采取自愿现场纠正措施
整改
Stryker宣布对部分LIFEPAK 15监护仪/除颤器采取自愿现场纠正措施。设备的Shock按钮可能因氧化而无法发出除颤电击；公司表示正联系客户安排纠正，包括更换受影响的键盘。该公告仅涉及相关设备，并将此行动描述为自愿性质。
品牌回应
整改 — Stryker
The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include replacement of the affected keypad.
来源摘录
The company is notifying a population of LIFEPAK 15 customers of an issue that may cause their devices to fail to deliver a defibrillation shock after the "Shock" button on the keypad is pressed. This is a result of oxidation that may have formed over time within the "Shock" button.
Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 monitor/defibrillators.
2019
Stryker 对 LIFEPAK 15 设备启动纠正措施
整改
Stryker 宣布对部分 LIFEPAK 15 监护除颤仪采取自愿现场纠正措施。相关问题可能导致设备在按下“Shock”按钮后无法放电。Stryker 表示将联系受影响客户安排纠正措施，包括更换受影响的键盘。
品牌回应
整改 — Stryker
The company is contacting customers with impacted devices to schedule the correction of their device(s), which will include replacement of the affected keypad.
来源摘录
Company Announcement Date: December 27, 2019
Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 monitor/defibrillators.
The company is notifying a population of LIFEPAK 15 customers of an issue that may cause their devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.
2018
2013
2012
2012
Rejuvenate和ABG II髋关节系统争议
史赛克的Rejuvenate和ABG II髋关节置换系统在报告称这些设备可能导致严重疼痛和其他并发症后，成为FDA行动、召回相关后果、诉讼和罚款的对象。
2008
2007